Search Results - "Raffin, Caroline"
-
1
Treg cell-based therapies: challenges and perspectives
Published in Nature reviews. Immunology (01-03-2020)“…Cellular therapies using regulatory T (T reg ) cells are currently undergoing clinical trials for the treatment of autoimmune diseases, transplant rejection…”
Get full text
Journal Article -
2
The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
Published in Frontiers in immunology (23-03-2021)“…Anti-CD19 chimeric antigen receptor (CD19-CAR)-engineered T cells are approved therapeutics for malignancies. The impact of the hinge domain (HD) and the…”
Get full text
Journal Article -
3
MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer
Published in Haematologica (Roma) (01-02-2013)“…Generation of tumor-antigen specific CD4(+) T-helper (T(H)) lines through in vitro priming is of interest for adoptive cell therapy of cancer, but the…”
Get full text
Journal Article -
4
Human RORγt⁺ TH17 cells preferentially differentiate from naive FOXP3⁺Treg in the presence of lineage-specific polarizing factors
Published in Proceedings of the National Academy of Sciences - PNAS (09-11-2010)“…RORγt⁺ TH17 cells are a proinflammatory CD4⁺ T-cell population associated with autoimmune tissue injury. In mice, priming of TH17 requires TGF-β, which alone…”
Get full text
Journal Article -
5
T reg cell-based therapies: challenges and perspectives
Published in Nature reviews. Immunology (01-03-2020)“…Cellular therapies using regulatory T (T ) cells are currently undergoing clinical trials for the treatment of autoimmune diseases, transplant rejection and…”
Get full text
Journal Article -
6
CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
Published in Cancer research (Chicago, Ill.) (01-09-2012)“…Antitumor type I T-cell responses involving IFN-γ production are critical to control cancer, but the efficacy of this response is limited by a variety of…”
Get full text
Journal Article -
7
T.sub.reg cell-based therapies: challenges and perspectives
Published in Nature reviews. Immunology (01-03-2020)“…Cellular therapies using regulatory T (T.sub.reg) cells are currently undergoing clinical trials for the treatment of autoimmune diseases, transplant rejection…”
Get full text
Journal Article -
8
Human memory Helios- FOXP3+ regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL-1β by downregulating their suppressor functions
Published in The Journal of immunology (1950) (01-11-2013)“…FOXP3(+) regulatory T cells (Tregs) are critical regulators of self-tolerance and immune homeostasis. In mice and humans, two subsets of FOXP3(+) Tregs have…”
Get full text
Journal Article -
9
Comment on "helios+ and helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans"
Published in The Journal of immunology (1950) (01-05-2013)Get full text
Journal Article -
10
Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells
Published in The Journal of immunology (1950) (15-11-2011)“…IL-17-producing CD4(+) Th (Th17) cells are a unique subset of proinflammatory cells expressing the retinoic acid-related orphan receptor γt and associated with…”
Get full text
Journal Article -
11
Generation of Th17 from human naive CD4+ T cells preferentially occurs from FOXP3+ Tregs upon costimulation via CD28 or CD5
Published in Blood (17-05-2012)Get full text
Journal Article -
12
Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis
Published in The Journal of immunology (1950) (01-05-2018)“…Abstract Rheumatoid arthritis (RA) is one of the most common chronic autoimmune diseases that is characterized by an aberrant inflammation of the synovial…”
Get full text
Journal Article -
13
Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis
Published in The Journal of immunology (1950) (01-05-2019)“…Abstract Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by an aberrant inflammation of the synovial membrane that causes irreversible…”
Get full text
Journal Article -
14
Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis
Published in The Journal of immunology (1950) (01-05-2016)“…Abstract Rheumatoid arthritis (RA) is one of the most common chronic autoimmune diseases with a frequency of 0.5–1.0% in the adult population of developed…”
Get full text
Journal Article -
15
Natural CXCR3+ FOXP3+ Treg selectively accumulate in human ovarian carcinomas to control type I immunity (127.27)
Published in The Journal of immunology (1950) (01-05-2012)“…Abstract Anti-tumor type I T cell responses are critical to control cancer but their efficacy is limited by immunoregulatory mechanisms, including the action…”
Get full text
Journal Article -
16
Human ROR[gamma]t+ T^sub H^17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors
Published in Proceedings of the National Academy of Sciences - PNAS (09-11-2010)“…ROR...t... T...17 cells are a proinflammatory CD4... T-cell population associated with autoimmune tissue injury. In mice, priming of T...17 requires TGF-β,…”
Get full text
Journal Article -
17
Human RORγt + T H 17 cells preferentially differentiate from naive FOXP3 + Treg in the presence of lineage-specific polarizing factors
Published in Proceedings of the National Academy of Sciences - PNAS (09-11-2010)“…RORγt + T H 17 cells are a proinflammatory CD4 + T-cell population associated with autoimmune tissue injury. In mice, priming of T H 17 requires TGF-β, which…”
Get full text
Journal Article